Compare Maxindo Karya Anugerah Tbk. (MAXI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maxindo Karya Anugerah Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Maxindo Karya Anugerah Tbk. trades at Rp50 (market cap 480.5B, 125.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Maxindo Karya Anugerah Tbk. is far larger — about 2.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (187.4K versus 125.2K). Which is the better fit depends on your goals.
| MAXI | OBAT | |
|---|---|---|
Market Cap | 480.5B | 164.65B |
Volume | 125.2K | 187.4K |
Lot | 1.25K | 1.87K |
Turnover | 6.26M | 44.35M |
Average Price | 50 | 236.67 |
Value | 6.26M | 44.35M |
Indicative Equilibrium Price | 50 | 242 |
Indicative Equilibrium Volume | 4 | 500 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maxindo Karya Anugerah Tbk.
PT Maxindo Karya Anugerah Tbk (the Company) was established based on Notarial Deed No. 26 of Dwi Swandiani, S.H., dated July 11, 2002. The Company started its commercial operations in 2002.
Read more on MAXI →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
